Početna › Lupus › Pennsylvania
Kliničke studije za Lupus u državi Pennsylvania
14 studija za Lupus traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50365, Pittsburgh
U tijeku regrutacijaFaza 3
Od 16 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Temple University, Philadelphia
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Altoona Arthritis & Osteoporosis Center - Altoona Center for Clinical Research, Duncansville
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- University Of Pittsburgh, Pittsburgh
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Philadelphia
U tijeku regrutacijaFaza 3
Od 5 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Clinical Research Philadelphia, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07438496CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 10 do 29 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- Fox Chase Cancer Center- Temple BMT, Philadelphia
U tijeku regrutacijaFaza 2
Od 16 do 70 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT07328581A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0075, Philadelphia
- Local Institution - 0052, Philadelphia
U tijeku regrutacijaOpažajna studija
Od 16 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 26. kol 2026. · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Penn State MS Hershey Medical Center, Hershey
U tijeku regrutacijaFaza 3
Od 55 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 2
Od 8 do 25 godina · Oba spola · Ažurirano 14. lis 2025. · NCT05029336Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.